Does Market Volatility Impact Deciphera Pharmaceuticals, Inc.'s (NASDAQ:DCPH) Share Price?HomeMailNewsFinanceSportsEntertainmentSearchMobileMore...YAHOO_FINANCESearchSign inMailSign in to view your mailFinance HomeWatchlistsMy PortfolioScreenersPremiumMarketsIndustriesPersonal FinanceVideosNewsTechU.S. Markets closedS&P 5002,978.76-137.63(-4.42%)Dow 3025,766.64-1,190.95(-4.42%)Nasdaq8,566.48-414.29(-4.61%)Does Market Volatility Impact Deciphera Pharmaceuticals, Inc.'s (NASDAQ:DCPH) Share Price?Simply Wall StSimply Wall St.January 2, 2020ReblogShareTweetShareView photosIf you own shares in Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH) then it's worth thinking about how it contributes to the volatility of your portfolio, overall. In finance, Beta is a measure of volatility. Volatility is considered to be a measure of risk in modern finance theory. Investors may think of volatility as falling into two main categories. The first category is company specific volatility. This can be dealt with by limiting your exposure to any particular stock. The second sort is caused by the natural volatility of markets, overall. For example, certain macroeconomic events will impact (virtually) all stocks on the market.Some stocks are more sensitive to general market forces than others. Some investors use beta as a measure of how much a certain stock is impacted by market risk (volatility). While we should keep in mind that Warren Buffett has cautioned that 'Volatility is far from synonymous with risk', beta is still a useful factor to consider. To make good use of it you must first know that the beta of the overall market is one. Any stock with a beta of greater than one is considered more volatile than the market, while those with a beta below one are either less volatile or poorly correlated with the market. View our latest analysis for Deciphera Pharmaceuticals What we can learn from DCPH's beta valueZooming in on Deciphera Pharmaceuticals, we see it has a five year beta of 1.91. This is above 1, so historically its share price has been influenced by the broader volatility of the stock market. If this beta value holds true in the future, Deciphera Pharmaceuticals shares are likely to rise more than the market when the market is going up, but fall faster when the market is going down. Beta is worth considering, but it's also important to consider whether Deciphera Pharmaceuticals is growing earnings and revenue. You can take a look for yourself, below.NasdaqGS:DCPH Income Statement, January 2nd 2020MoreHow does DCPH's size impact its beta?With a market capitalisation of US$3.2b, Deciphera Pharmaceuticals is a pretty big company, even by global standards. It is quite likely well known to very many investors. It has a relatively high beta, suggesting it may be somehow leveraged to macroeconomic conditions. For example, it might be a high growth stock with lots of investors trading the shares. It's notable when large companies to have high beta values, because it usually takes substantial capital flows to move their share prices.What this means for you:Since Deciphera Pharmaceuticals has a reasonably high beta, it's worth considering why it is so heavily influenced by broader market sentiment. For example, it might be a high growth stock or have a lot of operating leverage in its business model. In order to fully understand whether DCPH is a good investment for you, we also need to consider important company-specific fundamentals such as Deciphera Pharmaceuticals’s financial health and performance track record. I urge you to continue your research by taking a look at the following:Future Outlook: What are well-informed industry analysts predicting for DCPH’s future growth? Take a look at our free research report of analyst consensus for DCPH’s outlook.Financial Health: Are DCPH’s operations financially sustainable? Balance sheets can be hard to analyze, which is why we’ve done it for you. Check out our financial health checks here.Other High-Performing Stocks: Are there other stocks that provide better prospects with proven track records? Explore our free list of these great stocks here.If you spot an error that warrants correction, please contact the editor at editorial-team@simplywallst.com. This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Simply Wall St has no position in the stocks mentioned.We aim to bring you long-term focused research analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Thank you for reading.ReblogShareTweetShareRecently ViewedYour list is empty.What to Read NextDicerna Pharmaceuticals (DRNA) Reports Q4 Loss, Lags Revenue EstimatesZacksChemicals firm charged over polluting French factory blazeAFPInvestors ditch market risk as stocks fall into correctionReutersRichard Branson’s Wealth Falls to Earth as Virgin Galactic SputtersBloombergA drug shortage due to the coronavirus is a 'considerable risk:' Fmr. FDA deputy commissionerYahoo Finance VideoMost face masks won’t protect you from the coronavirusYahoo FinanceAmid coronavirus, bitcoin has fallen 6% this week to below $8,800Yahoo FinanceEl-Erian: The Fed will cut rates in March, if not beforeYahoo Finance VideoHow Does China Grand Pharmaceutical and Healthcare Holdings Limited (HKG:512) Stand Up To These Simple Dividend Safety Checks?Simply Wall St.Don’t buy the stock dip yet, says Goldman as it warns coronavirus will wipe out earnings growth this yearMarketWatchBiocontainment expert on coronavirus: There's no need for average people to panic yetYahoo FinanceStock market live updates: Dow drops 1190 points amid coronavirus fears, S&P 500 sees fastest correction in historyYahoo FinanceCoronavirus-induced stock selloff means IPO market is 'on holiday': veteran IPO analystYahoo FinanceMarket Watcher: Over six months we will see the markets higher Yahoo Finance VideoHere's How We Evaluate China Gas Holdings Limited's (HKG:384) DividendSimply Wall St.Stock market live updates: Stock futures climb after historic rout; coronavirus fears persistYahoo Finance